| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantern Pharma Inc. | Director | Stock Option (Right to Buy) | 28,844 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc. | 09 Jan 2026 | 2 | $0 | 4 | Director | 13 Jan 2026, 16:05 |
| LTRN | Lantern Pharma Inc. | 19 Sep 2025 | 4 | $0 | 4 | Director | 23 Sep 2025, 16:05 |
| LTRN | Lantern Pharma Inc. | 24 Jul 2024 | 2 | +$11,994 | 4 | Director | 26 Jul 2024, 16:15 |
| LTRN | Lantern Pharma Inc. | 15 Jul 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:30 |
| LTRN | Lantern Pharma Inc. | 04 Nov 2021 | 1 | $0 | 4 | Director | 08 Nov 2021, 15:05 |